Morten Andersen

Morten Andersen

Professor

Member of:

    ORCID: 0000-0001-7029-2860

    Publication year:
    All
    11 - 17 out of 17Page size: 10
    Sort by: 1st author
    1. Published

      Adherence to Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Cross-National Comparison in Six European Countries (2008–2015)

      Sabaté, M., Vidal, X., Ballarin, E., Rottenkolber, M., Schmiedl, S., Grave, B., Huerta, C., Martin-Merino, E., Montero, D., Leon-Muñoz, L. M., Gasse, C., Moore, N., Droz, C., Lassalle, R., Aakjær, M., Andersen, M., De Bruin, M. L., Souverein, P., Klungel, O. H., Gardarsdottir, H. & 1 others, Ibáñez, L., 2021, In: Frontiers in Pharmacology. 12, 14 p., 682890.

      Research output: Contribution to journal › Journal article › Research › peer-review

    2. Published

      Artificial Intelligence in Pharmacoepidemiology: A Systematic Review. Part 2–Comparison of the Performance of Artificial Intelligence and Traditional Pharmacoepidemiological Techniques

      Sessa, Maurizio, Liang, D., Khan, A. R., Kulahci, M. & Andersen, Morten, 14 Jan 2021, In: Frontiers in Pharmacology. 11, 10 p., 568659.

      Research output: Contribution to journal › Review › Research › peer-review

    3. Published

      Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines

      Sessa, Maurizio, Kragholm, K., Hviid, Anders Peter & Andersen, Morten, 2021, In: Expert Opinion on Drug Safety. 20, 11, p. 1451-1453

      Research output: Contribution to journal › Journal article › Research › peer-review

    4. Published

      New Insight on the Safety of Erenumab: An Analysis of Spontaneous Reports of Adverse Events Recorded in the US Food and Drug Administration Adverse Event Reporting System Database

      Sessa, Maurizio & Andersen, Morten, 2021, In: BioDrugs. 35, 2, p. 215-227 13 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    5. Published

      Comparing risk of major bleeding between users of different oral anticoagulants in patients with nonvalvular atrial fibrillation

      Souverein, P. C., van den Ham, H. A., Huerta, C., Merino, E. M., Montero, D., Leon-Munoz, L. M., Schmiedl, S., Heeke, A., Rottenkolber, M., Andersen, Morten, Aakjær, Mia, De Bruin, M. L., Klungel, O. H. & Gardarsdottir, H., 2021, In: British Journal of Clinical Pharmacology. 87, 3, p. 988-1000

      Research output: Contribution to journal › Journal article › Research › peer-review

    6. Published

      Risk of ventricular arrhythmia and all-cause mortality with citalopram or escitalopram versus paroxetine and sertraline among older adults in Denmark: A registry-based cohort study

      Werther, S. K., Aakjær, Mia, Pape, K. & Andersen, Morten, 2021, In: Pharmacoepidemiology and Drug Safety. 30, S1, p. 409-409

      Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

    7. Published

      Major bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population-based cohort studies

      van den Ham, H. A., Souverein, P. C., Klungel, O. H., Platt, R. W., Ernst, P., Dell'Aniello, S., Schmiedl, S., Grave, B., Rottenkolber, M., Huerta, C., Martin Merino, E., Leon-Munoz, L. M., Montero, D., Andersen, Morten, Aakjær, Mia, De Bruin, M. L. & Gardarsdottir, H., 2021, In: Pharmacoepidemiology and Drug Safety. 30, 10, p. 1339-1352

      Research output: Contribution to journal › Journal article › Research › peer-review

    Previous 1 2 Next

    ID: 169399129